Unlock measurable value at every stage of the clinical development and commercialization journey.
Our end-to-end solution that sets a new standard in patient access.
In this episode of Trending Health, we explore how the Inflation Reduction Act (IRA) is reshaping strategy across the life sciences industry.
Mindy McGrath is joined by Inizio Ignite colleagues, Scott Briggs and Ethan Johnson, to discuss how manufacturers are responding to Medicare price negotiation, Part D redesign, and increasing pressures on pricing and access.
The conversation highlights what has surprised leaders so far, how payer dynamics are evolving, and how companies are rethinking portfolio and lifecycle decisions in a more constrained market.
As future negotiation rounds approach, the episode offers a clear view into where organizations are focusing—and what they should be preparing for next.
Panel –Mindy McGrath, Scott Briggs, Ethan Johnson
Recording & Editing – Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com.
16 April 2026
As we kick off 2026, Mindy sits down with Inizio Ignite Global President, Remco op den Kelder, to discuss the industry...
Listen nowThe rules of product launch are changing fast. Policy reform, payer pressure, AI adoption, and shifting system dynamics...
Listen nowThe traditional path to patients is being rewritten. As affordability pressures rise and patient expectations shift,...
Listen now
